Closing Panel: What Will Oncology Drug Delivery Look Like in 2030?

13 Oct 2026
Precision Targeting , RNA Delivery , Biologics Formulation , Scale-Up & Manufacturing
  • Precision Delivery at Scale.
  • Emerging Modalities and Platforms.
  • Predictions for Oncology 2030.
Speakers
Vinu Krishnan
Vinu Krishnan, Principal Research Scientist - AbbVie
Mark Eccleston
Mark Eccleston, Chief Executive Officer - ValiRx
Kinkini Roy
Kinkini Roy, Director, Formulation & Drug Product Development - Aviceda Therapeutics
Roelof Rongen
Roelof Rongen, Chief Executive Officer, Adolore Biotherapeutics, Co-Founder AeirBio - AeirBio